From 1992 to 1993, reported AIDS cases in the U.S. more than doubled, from 47,572 to 106,949 cases.1
Number of EMAs now at 25.
The CDC revises AIDS clinical trial guidelines requiring women and minorities to be included in studies.2
Researchers in France and Britain conclude that the AIDS treatment AZT has little or no benefit when taken early in the progression of the disease.3
The female condom is approved by the FDA.4
25 METRO AREAS NOW ELIGIBLE FOR CARE ACT FUNDING
With AIDS incidence and mortality skyrocketing, seven more metropolitan regions became eligible for Title I (Part A) funding as Eligible Metropolitan Areas, bringing the total to 25. A year earlier, in 1992, two regions were added to the 16 funded in 1991.
Areas eligible for funding under Title I statutes are those with:
- More than 2,000 reported AIDS cases in the most recent five-year period, and
- Populations of at least 500,000.
Many elements made the Title I program unique among other Ryan White HIV/AIDS Program Initiatives. For example, as adopted, a local planning council, comprised of at least 25 percent people living with HIV/AIDS (PLWHA), established spending priorities for the jurisdiction. (That proportion has since been raised to 33 percent.) Priorities were based on needs assessments among the local HIV-positive population.
The grantee's administrative agency (which is, typically, the local health department) enters into contracts with local providers of services to PLWHA.
With the Ryan White HIV/AIDS Treatment Modernization Act of 2006, several changes were made in the Part A Program.
In 1991, when the CARE Act was first funded, Titles I and II were funded evenly, at approximately $87.8 million. However, in the years immediately following, Title I funding grew more significantly than did funding for Title II. Title I funding remained higher than that for Title II until 1998, by which time appropriations to ADAP were growing more rapidly than for any other program.
